Active Ingredient(s):Terlipressin FDA Approved: * September 14, 2022 Pharm Company: *MALLINCKRODT Category:Esophageal Varices
Terlipressin (trade names Teripress by New Medicon Pharma and Glypressin by Ferring Pharmaceuticals) is an analogue of vasopressin used as a vasoactive drug in the management of low blood pressure. It has been found to be effective when norepinephrine does not help.
Indications for use include norepinephrine-resistant septic shock and hepatorenal syndrome. In addition, it is used to treat bleeding esophageal varices.
* May have multiple approval dates, manufacturers, or labelers.
Terlivaz .85 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution